The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
Sponsor: Istanbul Medeniyet University
Listed as NCT04617743, this observational or N/A phase trial focuses on Bladder Cancer Recurrent and Non-Invasive Bladder Urothelial Carcinoma and remains ongoing. Sponsored by Istanbul Medeniyet University, it has been updated 7 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
May 2022 — May 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — May 2022 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Istanbul Medeniyet University
For direct contact, visit the study record on ClinicalTrials.gov .